Per Malmström

Effect of Tailored Dose-Dense Chemotherapy vs Standard 3-Weekly Adjuvant Chemotherapy on Recurrence-Free Survival Among Women With High-Risk Early Breast Cancer: A Randomized Clinical Trial.

Michael Gnant, Jonas Bergh, Richard Greil, 2016, JAMA.

Topoisomerase IIalpha gene amplification predicts favorable treatment response to tailored and dose-escalated anthracycline-based adjuvant chemotherapy in HER-2/neu-amplified breast cancer: Scandinavian Breast Group Trial 9401.

Jorma Isola, Jonas Bergh, Nils Wilking, 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.